Plain-English translation of NCT07906665 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
Phase
Safety & dosing
Sponsor
Sachi Bioworks Inc.
Enrollment target
~40 participants
Started
January 2027
Primary completion
March 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Prashant Nagpal, Ph.D.
Mayo Clinic Rochester, Rochester, MN
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.